BioScrip, Inc. (NASDAQ:BIOS)

CAPS Rating: 2 out of 5

The Company provides pharmaceutical and pharmacy benefit management services.

Recs

0
Player Avatar biovestor (< 20) Submitted: 6/28/2008 6:28:04 AM : Outperform Start Price: $2.69 BIOS Score: +143.64

A specialty small/micro-cap pharmacy benefit manager in an industry group that is currently out of favor, but likely to rebound strongly or be acquired over the next year or so.

Featured Broker Partners


Advertisement